Screener
Oruka Therapeutics, Inc. ORKA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 318 | 288 |
| Operating lease right-of-use assets | 1,687 | 1,830 |
| Other non-current assets | 103 | 103 |
| Total assets | $504,480 | $488,617 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $3,662 | $4,155 |
| Accrued expenses and other current liabilities | 9,287 | 10,591 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s total assets?
- Oruka Therapeutics, Inc. (ORKA) reported total assets of $504.48M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total assets changed year-over-year?
- Oruka Therapeutics, Inc.'s total assets increased by 33.8% year-over-year, from $377.11M to $504.48M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total assets has grown at a 57.5% compound annual growth rate (CAGR), from $50.43M to $488.62M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Oruka Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude